KEGG   DRUG: Lidocaine hydrochloride and epinephrine bitartrate
Entry
D04813            Mixture   Drug                                   
Name
Lidocaine hydrochloride and epinephrine bitartrate;
Lidocaine hydrochloride and adrenaline bitartrate;
Ora (TN);
Lidosite (TN)
Product
  Generic
Component
(Lidocaine hydrochloride [DR:D02086] | Lidocaine hydrochloride monohydrate [DR:D08127]), Epinephrine bitartrate [DR:D02149]
Class
Metabolizing enzyme substrate
 DG01892  CYP1A2 substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Remark
Therapeutic category: 2710
Product: D04813<JP/US>
Efficacy
Anesthetic (topical, dental)
Metabolism
Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]
Interaction
Brite
USP drug classification [BR:br08302]
 Anesthetics
  Local Anesthetics
   Lidocaine/ Epinephrine
    D04813  Lidocaine hydrochloride and epinephrine bitartrate
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  27  Dental preparations
   271  Local anesthetics
    2710  Local anesthetics
     D04813  Lidocaine hydrochloride and epinephrine bitartrate
Drug groups [BR:br08330]
 Metabolizing enzyme substrate
  DG01892  CYP1A2 substrate
   D04813  Lidocaine hydrochloride and epinephrine bitartrate
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D04813  Lidocaine hydrochloride and epinephrine bitartrate
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D04813
Other DBs
PubChem: 17398182
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system